GC-MSC-derived IL-8 enhanced the proliferation, migration, and proangiogenesis ability of GC cells partly by regulating the activation of Akt or Erk1/2 pathway.
GC-MSC-CM remarkably prompted the chemotaxis of neutrophils and skewed them towards the activated state through GC-MSC-CM-derived IL-6 that mediated the activation of STAT3-ERK1/2 signaling in neutrophils, which could promote migration and angiogenesis of GC.
GC-MSC-CM could obviously reverse the inhibitory effects of peripheral blood mononuclear cells (PBMCs) on the GC growth. And GC-MSC-CM dampened Treg/Th17 balance in PBMCs.